Antibiotic policy-Slovenian experiences

Antibiotic Policies: Theory and Practice

Volumn , Issue , 2005, Pages 251-260

  Čižman, Milan ^a   Beović, Bojana ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 45349107838     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-22852-7_14     Document Type: Chapter

References (31)

1. Beovic, B., Matos, B., Bosnjak, R., Seme, K., Mueller-Premru, M., Hergouth-Krizan, V. et al., 2003, Prevention of nosocomial lower respiratory tract infections in patients after intracranial artery aneurysm surgery with a short course of antimicrobials. Int. J. Antimicrob. Agents, 21.
2. Cernelc, V, 2002, Utilization review of systemic antimicrobials in Slovene hospitals. Med. Razgl., 41(Suppl.), 43-42.
3. Cizman, M. and Beovic, B., 2002, Prirocnik za ambulantno predpisovanje protimikrobnih zdravil. Arkadia.
4. Cizman, M. and Marolt, M., 1998, Priporocila za uporabo protimikrobnih zdravil KC 1998. Komisija za antibiotike v KC, Klinicni center, Sekcija za kemoterapijo SZD
5. Cizman M., Orazem, A., Krizan-Hergouth V, and Kolman, J. 2001a, Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections. J. Antimicrob. Chemother, 47, 502.
6. Cizman, M., Pecar-Cad, S., Stefancic, M., Elseviers, M., Ferech, M., Van der Stichele, R. et al. 2003, Consumption of antibiotics in Slovenia, first results of the ESAC retrospective data collection. ESCMID Meeting, Glasgow.
7. Cizman, M., Pokorn, M., Paragi, M., and the Slovenian Meningitis Study Group, 2002, Antimicrobial resistance of invasive Streptococcus pneumoniae in Slovenia from 1997 to 2000. J. Antimicrob. Chemother, 49, 582-584.
8. Cizman, M., Pokorn, M., Seme, K., and Orazem, A., 2001b, The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J. Antimicrob. Chemother, 47, 475-477.
9. Cizman, M., Pokorn, M., Seme, K., Paragi, M., and Orazem, A., 1999, Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. Eur J. Clin. Microbiol. Infect. Dis., 18, 522-524.
10. Danmap, Danmap 2000-Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. ISSN 1600-2032.
11. ESAC-European Surveillance of Antimicrobial Consumption, 2002, Interim report, November 2001-2, 51-76.
12. Fürst, J., 2001, Primerjava uporabe zdravil v otroski dobi v Sloveniji in Skandinaviji. In C. Krzisnik and T. Battelino (eds.), Izbrana poglavja iz pediatrije. Medicinska fakul-teta Univerze v Ljubljani, Katedra za pediatrijo, pp. 71-76.
13. Gould, I. M., 1999, Stewardship of antibiotic use and resistance surveillance: the international scene. J. Hosp. Infect., 43(Suppl.), 253-260.
14. Gould, I. M., 2002, Antibiotic policies and control of resistance. Curr. Opin. Infect. Dis., 15, 395-400.
15. Institute of Public Health of the Republic of Slovenia. Health Statistical Year Book, 2002, Hospital treatment of diseases.
16. Janknegt, R., Lashof, A. O., Gould, I. M., and van der Meer, J. W. M., 2000, Antibiotic use in Dutch hospitals 1991-1996. J. Antimicrob. Chemother., 45, 251-256.
17. Keuleyan, E. and Gould, I. M., 2001, Key issues in developing antibiotic policies: From an institutional level to Europe-wide, European Study Group on Antibiotic Policy (ESGAP), Subgroup III. Clin. Microbiol. Infect., 7, 16-21.
18. Krcmery, V, Jeljaszewicz, J., Grzesiowski, P., Hryniewicz, W, Metodiev, K., Stratchounski, L. et al., 2000, National and local antibiotic policies in central and eastern Europe. J. Chemother, 12, 471-474.
19. Marolt-Gomiscek, M. and Cizman, M., 1992, The usage of antibiotics for outpatients and recommendations for the treatment of bacterial infections. Zdrav. Vestn., 61, 403-406.
20. Mueller-Premru, M., Seme, K., Krizan-Hergouth, V, Andlovic, A., Kolman, J., and Gubina, M., 2002, Trends of bacterial resistance at the University Medical Center in Ljubljana. Med. Razgl., 41(Suppl. 2), 25-34.
21. Orazem, A. and Milovanovic, M., 1996, Out-patient prescribing of antibacterials for systemic use in Slovenia. Med. Razgl., 35(Suppl. 1), 1-11.
22. Sørenson, L. T, and Monnet, D., 2002, Control of antibiotic use in the community: The Danish experience. Infect. Control Hosp. Epidemiol., 21, 387-389.
23. Standing Medical Advisory Committee, 1998, Subgroup on Antimicrobial Resistance, the path of least resistance. Department of Health http://www.doh.gov.uk/smac.thm
24. Struelens, M. J., Byl, B., and Vincent, J. L., 1999, Antibiotic policy: A tool for controlling resistance of hospital pathogens. Clin. Microbiol. Infect., 5(Suppl.), 19-24.
25. Sibanc, B., Lesnicar, G, and Tratar, F., 2002, Results of controlled antimicrobial treatment at the Celje general hospital between 1995-2000. Med. Razgl., 41(Suppl.), 53-60.
26. The Swedish Strategic Programme for the rational use of antimicrobial agents (Strama), 2001, O. Cars K. Ekdahl (eds.) Swedres 2001, A report on Swedish antibiotic utilisation and resistance in human medicine. The Swedish Strategic Programme for the Rational Use of Antimicrobial Agents (STRAMA) and the Swedish Institute for Infectious Disease Control, 23-26.
27. Van der Meer, J. W. M. and Gyssens, I. C, 2001, Quality of antimicrobial drug prescription in hospital. Clin. Microbiol. Infect., 7(Suppl. 6), 12-15.
28. Vizintin, T. and Cizman, M., 1998, Antimicrobial usage and trends in the University Medical Centre in Ljubljana from 1995 to 1997. Zdrav. Vestn., 67, 721-725.
29. White, A. C. Jr., Atmar, R L., Wilson, J., Cate, T. R, Stager, C. E., and Greenberg, S. B., 1997, Effects of requiring prior authorization for selected antimicrobials: Expenditures, susceptibilities, and clinical outcomes. Clin. Infect. Dis., 25, 230-239.
30. WHO Collaborating Centre for Drug Statistics Methodology, 2001, Guidelines for ATC classification and DDD assignment. Oslo.
31. Wilton, P., Smith, R, Coast, J., and Millar, M., 2002, Strategies to contain the emergence of antimicrobial resistance: A systematic review of effectiveness and cost-effectiveness. J. Health Serv. Res. Policy, 7, 111-117.